Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phyllis I Spuls

Showing results (111-120 of 126) with videos related to

Pageof 13
Sort By:
Acta Dermato-Venereologica|February 7, 2018
Initial Results of Secukinumab Drug Survival in Patients with Psoriasis: A Multicentre Daily Practice Cohort StudyJuul M P A van den Reek, Lieke J van Vugt, Martijn B A van Doorn, et al.
The Journal of Investigative Dermatology|September 5, 2025
Implementing Federated Analysis using DataSHIELD in the DREAM TO TREAT Atopic Dermatitis Registries CollaborationNiels Steen Krogh, David Prieto-Merino, Bolaji Coker, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 28, 2022
The effects of systemic immunomodulatory treatments on COVID-19 outcomes in patients with atopic dermatitis: Results from the global SECURE-AD registryAnnelie H Musters, Conor Broderick, David Prieto-Merino, et al.
Journal of the American Academy of Dermatology|August 15, 2017
When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema CouncilEric L Simpson, Marjolein Bruin-Weller, Carsten Flohr, et al.
Allergy|March 5, 2024
Suppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after mRNA vaccinationAnika M Valk, Jim B D Keijser, Koos P J van Dam, et al.
Anais Brasileiros De Dermatologia|June 11, 2023
Consensus on the therapeutic management of atopic dermatitis ‒ Brazilian Society of Dermatology: an update on phototherapy and systemic therapy using e-Delphi techniqueRaquel Leao Orfali, Daniel Lorenzini, Aline Bressan, et al.
The British Journal of Dermatology|February 1, 2022
Vaccine hesitancy and access to psoriasis care during the COVID-19 pandemic: findings from a global patient-reported cross-sectional surveyKatie Bechman, Emma S Cook, Nick Dand, et al.
BMC Medicine|March 3, 2022
Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseasesLuuk Wieske, Laura Y L Kummer, Koos P J van Dam, et al.
Journal of Autoimmunity|January 9, 2023
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinationsKoos P J van Dam, Luuk Wieske, Eileen W Stalman, et al.
BMC Infectious Diseases|May 17, 2023
Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activityKoos P J van Dam, Adriaan G Volkers, Luuk Wieske, et al.
Pageof 13

Showing results (111-120 of 126) with videos related to

Sort By:
Pageof 13
Acta Dermato-Venereologica|February 7, 2018
Initial Results of Secukinumab Drug Survival in Patients with Psoriasis: A Multicentre Daily Practice Cohort StudyJuul M P A van den Reek, Lieke J van Vugt, Martijn B A van Doorn, et al.
The Journal of Investigative Dermatology|September 5, 2025
Implementing Federated Analysis using DataSHIELD in the DREAM TO TREAT Atopic Dermatitis Registries CollaborationNiels Steen Krogh, David Prieto-Merino, Bolaji Coker, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 28, 2022
The effects of systemic immunomodulatory treatments on COVID-19 outcomes in patients with atopic dermatitis: Results from the global SECURE-AD registryAnnelie H Musters, Conor Broderick, David Prieto-Merino, et al.
Journal of the American Academy of Dermatology|August 15, 2017
When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema CouncilEric L Simpson, Marjolein Bruin-Weller, Carsten Flohr, et al.
Allergy|March 5, 2024
Suppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after mRNA vaccinationAnika M Valk, Jim B D Keijser, Koos P J van Dam, et al.
Anais Brasileiros De Dermatologia|June 11, 2023
Consensus on the therapeutic management of atopic dermatitis ‒ Brazilian Society of Dermatology: an update on phototherapy and systemic therapy using e-Delphi techniqueRaquel Leao Orfali, Daniel Lorenzini, Aline Bressan, et al.
The British Journal of Dermatology|February 1, 2022
Vaccine hesitancy and access to psoriasis care during the COVID-19 pandemic: findings from a global patient-reported cross-sectional surveyKatie Bechman, Emma S Cook, Nick Dand, et al.
BMC Medicine|March 3, 2022
Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseasesLuuk Wieske, Laura Y L Kummer, Koos P J van Dam, et al.
Journal of Autoimmunity|January 9, 2023
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinationsKoos P J van Dam, Luuk Wieske, Eileen W Stalman, et al.
BMC Infectious Diseases|May 17, 2023
Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activityKoos P J van Dam, Adriaan G Volkers, Luuk Wieske, et al.
Pageof 13